Close

AUXL Financial Facts

Total operating expenses: 132.82M
Weighted average common shares outstanding: 50.4M
See Full Income Statement

Commitments and contingencies: 0
Short-term investments: 3.84M
See Full Balance Sheet

Auxilium Pharmaceuticals Inc. (AUXL) Earnings

  |   Expand Research on AUXL
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -11.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -4.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/30/14 Q314 $0.27$0.10 +$0.17$109.6M$101.02M = Details
8/7/14 Q214 -$0.44-$0.21 -$0.23$83M$88.52M = Details
5/5/14 Q114 -$0.39-$0.17 -$0.22$8.5M$89.2M = Details
2/28/14 Q413 $0.27$0.22 +$0.05$125.9M$111.83M = Details
11/6/13 Q313 $0.17$0.15 +$0.02$108.1M$103.66M = Details
8/1/13 Q213 $0.02-$0.03 +$0.05$100.5M$91.43M = Details
4/29/13 Q113 -$0.05$0.02 -$0.07$66.2M$81.23M = Details
2/26/13 Q412 $1.83$1.72 +$0.11$172.5M$171.2M = Details